About

Proteovant is a pioneering protein degradation company focused on discovering and developing transformative medicines to treat patients with life-altering diseases. We are pursuing this expansive field with speed, scale and intention. We integrate extensive biology knowledge and a drug hunter’s intuition with deep, proprietary artificial intelligence technologies to deliver a robust pipeline that spans a range of novel molecular targets across multiple therapeutic areas. Additionally, we have the strong backing and life sciences expertise of our parent company, Roivant Sciences. Roivant is a next-generation biopharmaceutical company organized to harness modern technologies and the entrepreneurial spirit of nimble biotechnology companies at scale, bringing end-to-end development capabilities and world-class collaborators in the field of protein degradation to propel us ahead in our mission.